OVERVIEW

The global market for preclinical imaging is projected to hit USD 1.88 billion by 2026; rising at a CAGR of 5% in 2021-2026. A number of factors such as technological advancements in molecular imaging, increased consumer demand for non-invasive small animal imaging techniques, and a increasing number of public-private partnerships and funding to support preclinical research are driving the growth of the global market for preclinical imaging. In the following report, the impact of the COVID-19 outbreak on the industry will be fully assessed. The reports also compares the markets of Pre COVID-19 and Post COVID-19.

TABLE OF CONTENT

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Preclinical Imaging (In-VIVO) Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Preclinical Imaging (In-VIVO) Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Preclinical Imaging (In-VIVO) Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global Preclinical Imaging (In-VIVO) Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Preclinical Imaging (In-VIVO) Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Preclinical Imaging (In-VIVO) Market ? By Modality (Market Size ? & million/billion)
  • 8.1 Optical Imaging Systems
  • 8.2 Preclinical Nuclear Imaging Systems
  • 8.3 Micro-Ultrasound Systems
  • 8.4 Micro-CT Systems
  • 8.5 Preclinical Magnetic Particle Imaging (MPI) Systems
  • 8.6 Others

• 9 Global Preclinical Imaging (In-VIVO) Market - By Reagents
  • 9.1 Preclinical Optical Imaging Reagents
  • 9.2 Preclinical MRI Contrast Agents
  • 9.3 Preclinical Nuclear Imaging Reagents
  • 9.4 Preclinical Ultrasound Contrast Agents
  • 9.5 Preclinical CT Contrast Agents

• 10 Global Preclinical Imaging (In-VIVO) Market ? By Geography (Market Size ? &

• • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 U.K
    • 10.3.2 Germany
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia-Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 South Korea
    • 10.4.5 Rest of APAC
  • 10.5 Rest of the World
    • 10.5.1 South America
    • 10.5.2 Middle East
    • 10.5.3 Africa

• 11 Global Preclinical Imaging (In-VIVO) Market ? Entropy
  • 11.1 New product launches
  • 11.2 M&A's, collaborations, JVs and partnerships

• 12 Global Preclinical Imaging (In-VIVO) Market Company Profile (Key Players)
  • 12.1 Market Share, Company Revenue, Products, M&A, Developments
  • 12.2 Fujifilm Holdings Corporation
  • 12.3 Bruker Corporation
  • 12.4 Perkinelmer, Inc.
  • 12.5 Milabs B.V.
  • 12.6 Trifoil Imaging
  • 12.7 Miltenyi Biotec GmbH
  • 12.8 Mediso Ltd.
  • 12.9 Aspect Imaging Ltd.
  • 12.10 MR Solutions Ltd.
  • 12.11 Li-Cor Biosciences
  • 12.12 Company 11 & more

• 13 Global Preclinical Imaging (In-VIVO) Market - Appendix
  • 13.1 Sources
  • 13.2 Abbreviations